Mednet Logo
HomeGynecologic Oncology
Gynecologic Oncology

Gynecologic Oncology

Clinical discussions on gynecologic malignancies, surgical approaches, and multimodal treatment strategies.

Recent Discussions

How do you counsel patients and partners of patients with HPV+ cancers regarding the HPV vaccine?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

The patient was likely exposed in their teens or twenties. The partner is likely too old to be vaccinated. Independent of the cancer, children should be vaccinated.

How would you approach an HPV+ retroperitoneal mass s/p resection involving the psoas/ureter, with uterus/cervix negative for any cancer?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

When the PET and EUA are negative, I have treated HPV positive unknown primary with post-op or definitive chemo RT based on location. There is limited published data on HPV positive groin or pelvic nodes with occult primary. The last one I treated for unresectable RP mass had good response locally b...

What is the role of SBRT in recurrent oligometastatic ovarian cancer?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Ovarian granulosa cell tumor are not as chemo sensitive and respond more to local treatment and have long disease free interval and longer time to recur. Surgery where feasible and if not local treatment with fractionated IMRT or SBRT is reasonable based on location and extent of disease to prolong ...

What personnel does your department require to safely deliver vaginal cylinder brachytherapy, other than treating radiation oncologist and physicist?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Ohio State University Hospital

We have dedicated nursing staff and specialized brachytherapy radiation therapists who are all integral for all of our procedures, including vaginal cylinder brachytherapy.

How do you approach adjuvant treatment of non-uterine leiomyosarcoma?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · Emory University

I do not offer adjuvant chemotherapy to persons with leiomyosarcoma. One can make a case that the large negative randomized study EORTC 62931 published in 2012 supplants the 2008 meta-analysis of smaller studies that showed survival benefit from adjuvant chemo. Woll et al., PMID 22954508Neither is t...

Would you offer adjuvant radiotherapy to a recurrent HPV-independent vulvar cancer located close to the anus, which was resected with very close (0.8 mm) margins?

1
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would favor RT and include the inguinal region as with local recurrence, there is about a 15% risk of nodal involvement.

What is the optimal treatment for adenocarcinoma of the vulva?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I don’t know what is optimal but usually, they are associated with Paget's disease or Bartholin gland tumor and we follow the surgical principle same as SCC followed by adjuvant RT as indicated based on margin or nodal status.

What is your treatment approach for a pediatric patient with uterine embryonal rhabdomyosarcoma found after removal of a prolapsing uterine mass, with no evidence of distant metastasis on imaging?

1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Connecticut Children's Medcl Center

Based on the location of the uterus, this would be a favorable site. In the scenario presented, the tumor is noted to be removed, but the margin status is not noted, which could greatly affect the approach. Also, the exact uterine location (such as cervix vs body of the uterus) may make a difference...

How many cycles of BEP would you treat an immature teratoma of the ovary?

1 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Baylor College of Medicine

Assuming we are discussing a grade 2 or 3 stage I IT or stage II-IV IT, the standard of care would be to provide 4 cycles of BEP (although some have advocated for 3 cycles of BEP for low risk disease and 4 for high risk disease). (Brown et al., PMID 25341580) Following this, if tumor markers are sti...

Is there a valid hypofractionated regimen for postop cervical/endometrial cancers given COVID-19?

5
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

There are no good prospective series of hypofractionation for cervix and endometrial cancer in the curative setting.